MUMBAI (Reuters) - The UK's healthcare regulator has decided to suspended marketing approval for a widely used antibiotic that had won clearance based on clinical trials conducted by India's Quest Life Sciences, due to concerns over the integrity of trial data.
from Reuters: Top News http://uk.reuters.com/article/uk-india-pharmaceuticals-quest-idUKKCN0ZH4ZE?feedType=RSS&feedName=topNews
No comments:
Post a Comment